Member Info for Sangijuelas1

Haha looks like the short termers need to move on as potential won't be realised for years.

And Angle don't even want them as investors.

Love it

I mean regarding the NHS Parsortix is labelled as a research tool, not for clinical use.

So how are the NHS going to use it as a diagnostic?

They seem quite disparaging about the NHS.

Yet another UK company Endomag with a breast cancer spread diagnostic has managed to get their tech rolled out both in the US and across the NHS.

https://pharmaphorum.com/news/nice-endorses-magtrace-diagnostic-to-detect-breast-cancer-spread/

And below in my experience!

No one is talking about offering 90% of the placement to small investors but allocating say 10% on Primary Bid would be a nice gesture

What, serious investors like Jupiter?

It wouldn't be so expensive if they used Primary Bid.

That's a feeble excuse. Many decent small caps have used it recently

Fevertree do you know how many biotechs have their IPOs on hold at the moment due to the biotech bear market?

The market was flooded with them last year and the tap has been turned off, even for companies that have had successful trials

Good morning friends.

The annual report clearly states they need $45m once the current cash runs out.

The plan for the raise would have been in place since at least last July as it was made a condition of the release of Oxford loan funds.

The current market cap is $78m so if they can only raise 40% of market cap that would only be $31m.

If the SP were to drop more then a placing would get harder and harder with the 40% restriction in place.

So clearly they need freedom to be able to raise 100% of the value.

I don't think people get how partnerships between big pharma and small biotechs work. Big pharma are not charities that provide bailout funds to smaller companies that are struggling.

Merck has dozens of ongoing Keytruda collaborations with small biotechs. They are not going to fund each and every one that is running low on cash.

It's dog eat dog capitalism my friend. At 8am I will buy 1 share and then I can vote for the resolution and be free to comment here.

Well if you think it's worth so much more than it's priced at then surely you should be buying more rather than complaining?

Not going well at Gorillas. Gettir doing a bit better

https://sifted.eu/articles/gorillas-funding-struggles-layoffs/

There was an article in Seeking Alpha on liquid biopsy market a couple of hours before the FDA news yesterday.

Angle not even mentioned so I doubt there's much awareness among US investors.

And they have mostly lost their appetite for biotech.

Take Mirati Therapeutics- has an application in for fast track approval for a Kras Inhibitor. But not reflected in the value and down 62% since the start of the year.

Last week I said worth keeping an eye on Evelo as would have been running short of cash.

They have just today raised $80m so shows there's still investor appetite for microbiome stocks.

Wasn't a typical placing as they managed to do it without intermediaries (bankers). Mostly from a fund called Flagship who funded them before they listed them.

Was a shelf registration deal

I don't think it was mentioned.

So they are in the US at the moment.

What are they doing?

So to be clear. You were trying to encourage people to trade based on inside information?

Got some away now but had to break them up

Won't let me buy on AJ Bell

Have to not make the same mistake as investors in Solexa who sold out to Illumina for $650m and whose tech helped greatly to making Illumina the $50bn company they currently are

I am not selling. Current Mcap is ridiculous now that device cleared